(Shelton et al. Sertraline 50-100 Yes 8 T8 82 46.3 41.2 ±12.0 Personality 19 - Yes 2006)() disorders, other Venlafaxine 75-225 76 63.2 37.2±11.6 14 - axis I but MD as primary diagnosis (Shrivastava et Paroxetine 22.0-45.5 Yes 6 T6 40 27.5 38 No - 10 Yes al. 1992)() Placebo 40 35 34.6 - 6 (Silverstone et Fluoxetine 39.9 Yes 12 T12 121 59.7 43.2± 10.9 Anxiety 30 17 Yes al. 1999)() disorders Venlafaxine XR 140.8 128 63.9 41.1± 12.0 41 17 Placebo 119 57.6 41.6± 10.8 12 7 (Sir et al. Sertraline 105.4±29.5 No 8 T8 79 72.2 37.3± 13.5 No 28 17 Yes 2005)() Venlafaxine XR 161.4±44.4 84 66.7 36.8± 12.4 23 22 (Smith et al. Mirtazapine 18 No 6 T6 50 58 43 No - 32 No 1990)() Placebo 50 58 43 - 8 et al. Paroxetine 33.8 No 6 T6 39 38.5 44.9 No 8 7 Yes 1992)() Placebo 38 47.4 44.6 2 3 (Soares et al. Desvenlafaxine 177.2±40.6 No 8+26 T8 296 100 56± 6 No 39 48 Yes 2010)() Escitalopram 18.1±3.9 299 100 56± 6 33 42 (Sögaard et al. Sertraline 83.1 Yes 12 T12 99 79.8 42.1± 11.1 No 19 4 Yes 1999)() (Sonawalla et Fluvoxamine 143±45 No 12 T12 30 53.3 39.4 ±11.3 No 11 - Yes al. 1999)() (Sonawalla et Fluoxetine 20 No 8 T8 123 49 38.9 ±10.8 Anxiety 21 - No al. 2002)() disorders
(Shelton et al. 2006)() Sertraline Venlafaxine 50-100 75-225 Yes 8 T8 82 76 46.3 63.2 41.2 ±12.0 37.2±11.6 Personality disorders, other axis I but MD as primary diagnosis 19 14 - - Yes (Shrivastava et al. 1992)() Paroxetine Placebo 22.0-45.5 Yes 6 T6 40 40 27.5 35 38 34.6 No - - 10 6 Yes (Silverstone et al. 1999)() Fluoxetine Venlafaxine XR Placebo 39.9 140.8 Yes 12 T12 121 128 119 59.7 63.9 57.6 43.2± 10.9 41.1± 12.0 41.6± 10.8 Anxiety disorders 30 41 12 17 17 7 Yes (Sir et al. 2005)() Sertraline Venlafaxine XR 105.4±29.5 161.4±44.4 No 8 T8 79 84 72.2 66.7 37.3± 13.5 36.8± 12.4 No 28 23 17 22 Yes (Smith et al. 1990)() Mirtazapine Placebo 18 No 6 T6 50 50 58 58 43 43 No - - 32 8 No et al. 1992)() Paroxetine Placebo 33.8 No 6 T6 39 38 38.5 47.4 44.9 44.6 No 8 2 7 3 Yes (Soares et al. 2010)() Desvenlafaxine Escitalopram 177.2±40.6 18.1±3.9 No 8+26 T8 296 299 100 100 56± 6 56± 6 No 39 33 48 42 Yes (Sögaard et al. 1999)() Sertraline 83.1 Yes 12 T12 99 79.8 42.1± 11.1 No 19 4 Yes (Sonawalla et al. 1999)() Fluvoxamine 143±45 No 12 T12 30 53.3 39.4 ±11.3 No 11 - Yes (Sonawalla et al. 2002)() Fluoxetine 20 No 8 T8 123 49 38.9 ±10.8 Anxiety disorders 21 - No
JCP_00_00_2015_03_31_SERRETTI_JCP14173_SDC1.docx